REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Saramed Sdn. Bhd. (Malaysia)

Main Activities: Pharmacies and Drug Stores
Full name: Saramed Sdn. Bhd. Profile Updated: January 12, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Saramed Sdn. Bhd. is an enterprise in Malaysia, with the main office in Kuching. The enterprise currently operates in the Pharmacies and Drug Stores sector. It was first established on June 27, 2013. The latest financial highlights indicate a net sales revenue drop of 17.73% in 2025. Its’ total assets recorded a negative growth of 24.53%. In 2025, Saramed Sdn. Bhd.’s net profit margin increased by 21%.

Headquarters
No. 313, Sl 35, Lot 1207,, Smi Industrial Park, Ph 4, Jalan Bako
Kuching; Sarawak; Postal Code: 93050

Contact Details: Purchase the Saramed Sdn. Bhd. report to view the information.

Website: http://www.mediscientx.com

Basic Information
Financial Auditors:
Purchase the Saramed Sdn. Bhd. report to view the information.
Incorporation Date:
June 27, 2013
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
60%
Purchase this report to view the information.
40%
Subsidiaries
Takonut Sdn. Bhd.
70%
Company Performance
Financial values in the chart are available after Saramed Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
-17.73%▼
Total Operating Revenue
-17.73%▼
Operating Profit
96.84%▲
Net Profit/Loss for the Period
93.46%▲
Total Assets
-24.53%▼
Total Equity
-3.37%▼
Operating Profit Margin
22.66%▲
Net Profit Margin
21%▲
Return on Equity (ROE)
73.98%▲
Quick Ratio
0.18%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo